The panel outlines the stages of type 1 diabetes, focusing on the importance of early intervention to prevent complications of the disease.
Plasma Biomarkers Achieve High Accuracy for Confirmatory Aβ Positivity in Eligibility Test for DMT in Alzheimer Disease
Plasma assays combining p-tau217 and Aβ42/40 accurately confirm AD, supporting patient eligibility for anti-amyloid disease-modifying therapies.
Weekly Dose Podcast: Depression Risk After Chronic Illness, Vaginal Estradiol Safety, GLP-1 Updates, Cancer Risk Reduction, and Cardiovascular Outcomes
Today's episode covers depression risk after chronic illness, vaginal estradiol safety, GLP-1 updates, cancer risk, and cardiovascular outcomes.
Grail Reports Strong Performance for Galleri Blood Test Ahead of FDA Submission
GRAIL's PATHFINDER 2 study shows Galleri blood test detected 7 times more cancers when added to standard screenings, with 99.6% specificity and low false positives.
Cervical Cancer Screening: What Primary Care Physicians Need to Know
PODCAST: Family physician Ada Stewart, MD, shares practical strategies for cervical cancer screening and patient communication.
Real-Time CGM Reduces Risk of Large Newborns in Gestational Diabetes: Daily Dose
Your daily dose of the clinical news you may have missed.
Three GLP-1 Receptor Agonists Show Comparable Cardiorenal Protection in Large US Cohort with T2D
GLP-1 RAs liraglutide, semaglutide, and dulaglutide showed similar kidney and cardiovascular outcomes more than 20,000 US veterans with type 2 diabetes.